Preventing kidney injury after heart surgery
Official title: Efficacy of Mitochondrial Directed Therapy in Prevention of Cardiac Surgery Associated AKI Prevent Cardiac Surgery Associated AKI Trial (Prevent CSA-AKI Trial)
Run by George Washington University · NCT06620523 · Data updated 2026-11-12
This study is testing if Coenzyme Q10 and Glutathione can help prevent kidney injury in patients having heart surgery.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 242 (estimated) |
| Sponsor | George Washington University Academic / other |
| Locations | 1 site (Washington D.C., District of Columbia) |
| Status | Recruiting |
| Started | July 18, 2024 |
| Main results expected | June 17, 2027 |
| Study ends | June 17, 2028 |
| Registry record updated | October 14, 2026 |
| Trial ID | NCT06620523 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-70 who are scheduled for elective cardiopulmonary bypass surgery with a baseline GFR of 45 ml/min or higher.
✕Probably not a fit
Patients with a GFR below 45 ml/min, those with a solitary kidney, or individuals who have undergone kidney transplant will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial investigates the effectiveness of Coenzyme Q10 and Glutathione in preventing acute kidney injury (AKI) in patients undergoing elective cardiac surgery with cardiopulmonary bypass. A total of 242 participants will be randomly assigned to receive either the active treatment or a placebo, starting the day before surgery and continuing for up to one week post-operation. Blood and urine samples will be collected to monitor kidney function and any adverse effects related to the treatments. The study aims to address the high incidence of AKI following cardiac surgery, which can lead to severe complications and long-term health issues.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce the incidence of acute kidney injury in patients undergoing cardiac surgery, improving overall patient outcomes.
How similar studies have gone: While the approach of using CoQ10 and Glutathione for this purpose is innovative, similar studies targeting AKI prevention in cardiac surgery have shown varying degrees of success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult 18-70 years of age * Undergoing elective CPB (Cardiopulmonary Bypass) surgery * Baseline GFR (Glomerular Filtration Rate) ≥45 ml/min Exclusion Criteria: * GFR (Glomerular Filtration Rate) \<45 ml/min * Solitary kidney * Status post-kidney transplant * Pregnant women * Allergy to CoQ10 * Allergy to Glutathione * Allergy to Cellulose
Where it's running
-
George Washington University Hospital
Washington D.C., District of Columbia, United States Recruiting
Study contacts
- Principal investigator: Yoosif Abdalla, MD — George Washington University
- Study coordinator: Eduard Shaykhinurov, MS
- Email: eshaykhinurov@mfa.gwu.edu
- Phone: 2028234259
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
-
Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
-
Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease
This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.
-
Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance
This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.
-
Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in CABG Patients
This study tests whether the amount a patient’s pulse pressure varies during surgery relates to how quickly lactate levels drop after CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.